Literature DB >> 27910834

Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation.

Jacky S Bouanga Boudiombo1, Ayesha Jacobs1.   

Abstract

Mefenamic acid (MA) formed solvates with 2-picoline (2PIC), 3-picoline (3PIC), 4-picoline (4PIC) and 3-chloropyridine (3CLPYR). The solvates crystallized in the space group P\bar 1 with the carboxylic acid of MA hydrogen-bonded to the nitrogen of the substituted pyridine. Tolfenamic acid (TFA) formed solvates with 2PIC and 3PIC, the crystal structures successfully solved in the space groups P21/n and Pbca, respectively. The fenamate conformation varied depending on the acid and the included solvent. Similarities were observed in the structures involving MA. The two solvate structures of TFA had different packing arrangements. Grinding and slurry experiments were also successful for the preparation of all of the compounds except MA·2PIC. Recrystallization, grinding and slurry investigations of MA and 2PIC yielded a polymorph; the structure was successfully solved in P21/n. Additionally, the thermal stability of the solvates was determined. Desolvation experiments were also performed and the resultant powders were analysed using powder X-ray diffraction.

Entities:  

Keywords:  desolvation; fenamic acids; kinetics; picolines; polymorphism

Year:  2016        PMID: 27910834     DOI: 10.1107/S2052520616014128

Source DB:  PubMed          Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater        ISSN: 2052-5192


  2 in total

1.  Isomorphism: 'molecular similarity to crystal structure similarity' in multicomponent forms of analgesic drugs tolfenamic and mefenamic acid.

Authors:  Subham Ranjan; Ramesh Devarapalli; Sudeshna Kundu; Subhankar Saha; Shubham Deolka; Venu R Vangala; C Malla Reddy
Journal:  IUCrJ       Date:  2020-01-07       Impact factor: 4.769

2.  Crystal structures of tolfenamic acid polymorphic forms I and II with precise hydrogen-atom positions for nuclear magnetic resonance studies.

Authors:  Helen Blade; Charles D Blundell; Iñigo J Vitorica-Yrezabal
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2020-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.